Alcohol-induced changes in methylation status of individual CpG sites, and serum levels of vasopressin and atrial natriuretic peptide in alcohol-dependent patients during detoxification treatment

European Addiction Research

Volumn 20, Issue 3, 2014, Pages 143-150

  Glahn, Alexander ^a   Knorrenschild, Rafael Riera ^b,c   Rhein, Mathias ^a   Nassab, Mani Haschemi ^a   Gröschl, Michael ^d   Heberlein, Annemarie ^a   Muschler, Marc ^a   Frieling, Helge ^a   Bleich, Stefan ^a   Hillemacher, Thomas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Bezirksklinikum Obermain   (Germany)

^c Bezirksklinik Hochstadt Suchtfachklinik   (Germany)

^d CELERION   (United States)

Author keywords

Alcohol withdrawal; Atrial natriuretic peptide; Epigenetic regulation; Vasopressin

Indexed keywords

ALCOHOL; ATRIAL NATRIURETIC FACTOR; BISULFITE; VASOPRESSIN; VASOPRESSIN DERIVATIVE;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; BLOOD LEVEL; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; VASOPRESSIN BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; GENETICS; MALE; WITHDRAWAL SYNDROME; YOUNG ADULT; ATRIAL NATRIURETIC FACTOR BLOOD LEVEL; DETOXIFICATION; DSM-IV; EPIGENETICS; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; PROSPECTIVE STUDY; SMOKING HABIT; TREATMENT DURATION;

ADULT; ALCOHOLISM; ATRIAL NATRIURETIC FACTOR; CASE-CONTROL STUDIES; CPG ISLANDS; DNA METHYLATION; HUMANS; MALE; PROMOTER REGIONS, GENETIC; SUBSTANCE WITHDRAWAL SYNDROME; VASOPRESSINS; YOUNG ADULT;

EID: 84898927294     PISSN: 10226877     EISSN: 14219891     Source Type: Journal    
DOI: 10.1159/000357473     Document Type: Article

References (34)

1. Kohler S, Klimke S, Hellweg R, Lang UE: Serum brain-derived neurotrophic factor and nerve growth factor concentrations change after alcohol withdrawal: Preliminary data of a case-control comparison. Eur Addict Res 2013; 19: 98-104.
2. Hillemacher T, Bayerlein K, Wilhelm J, Poleo D, Frieling H, Ziegenbein M, Sperling W, Kornhuber J, Bleich S: Volume intake and craving in alcohol withdrawal. Alcohol Alcohol 2006; 41: 61-65.
3. Hillemacher T, Frieling H, Luber K, Yazici A, Muschler MA, Lenz B, Wilhelm J, Kornhuber J, Bleich S: Epigenetic regulation and gene expression of vasopressin and atrial natriuretic peptide in alcohol withdrawal. Psychoneuroendocrinology 2009; 34: 555-560.
4. Kiefer F, Andersohn F, Jahn H, Wolf K, Raedler TJ, Wiedemann K: Involvement of plasma atrial natriuretic peptide in protracted alcohol withdrawal. Acta Psychiatr Scand 2002; 105: 65-70.
5. D?ring WK, Herzenstiel MN, Krampe H, Jahn H, Pralle L, Sieg S, Wegerle E, Poser W, Ehrenreich H: Persistent alterations of vasopressin and N-terminal proatrial natriuretic peptide plasma levels in long-term abstinent alcoholics. Alcohol Clin Exp Res 2003; 27: 849-861.
6. Strohle A, Feller C, Strasburger CJ, Heinz A, Dimeo F: Anxiety modulation by the heart Aerobic exercise and atrial natriuretic peptide. Psychoneuroendocrinology 2006; 31: 1127-1130.
7. Wiedemann K, Jahn H, Yassouridis A, Kellner M: Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: Preliminary findings. Arch Gen Psychiatry 2001; 58: 371-377.
8. Antoni FA, Hunter EF, Lowry PJ, Noble JM, Seckl JR: Atriopeptin: An endogenous corticotropin-release inhibiting hormone. Endocrinology 1992; 130: 1753-1755.
9. Laczi F, Valkusz Z, Laszlo FA, Wagner A, Jardanhazy T, Szasz A, Szilard J, Telegdy G: Effects of lysine-vasopressin and 1-deamino-8-D-arginine- vasopressin on memory in healthy individuals and diabetes insipidus patients. Psychoneuroendocrinology 1982; 7: 185-193.
10. Landgraf R: Neuropeptides in anxiety modulation. Handb Exp Pharmacol 2005; 169: 335-369.
11. Mazzocchi G, Malendowicz LK, Rebuffat P, Tortorella C, Nussdorfer GG: Arginine-vasopressin stimulates CRH and ACTH release by rat adrenal medulla, acting via the V1 receptor subtype and a protein kinase C-dependent pathway. Peptides 1997; 18: 191-195.
12. Kaye WH, Weltzin TE: Neurochemistry of bulimia nervosa. J Clin Psychiatry 1991; 52(suppl):21-28.
13. Keck ME: Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety. Amino Acids 2006; 31: 241-250.
14. Surget A, Belzung C: Involvement of vasopressin in affective disorders. Eur J Pharmacol 2008; 583: 340-349.
15. Zelena D: Vasopressin in health and disease with a focus on affective disorders. Cent Nerv Syst Agents Med Chem 2012; 12: 286-303.
16. Hillemacher T, Kahl KG, Heberlein A, Musch-ler MA, Eberlein C, Frieling H, Bleich S: Appetite-and volume-regulating neuropeptides: Role in treating alcohol dependence. Curr Opin Investig Drugs 2010; 11: 1097-1106.
17. Mutschler J, Bilbao A, von Der Goltz C, Demiralay C, Jahn H, Wiedemann K, Spanagel R, Kiefer F: Augmented stress-induced alcohol drinking and withdrawal in mice lacking functional natriuretic peptide-A receptors. Alcohol Alcohol 2010; 45: 13-16.
18. Ruskoaho H: Atrial natriuretic peptide: Synthesis, release, and metabolism. Pharmacol Rev 1992; 44: 479-602.
19. Rodenhiser D, Mann M: Epigenetics and human disease: Translating basic biology into clinical applications. CMAJ 2006; 174: 341-348.
20. Auger CJ, Coss D, Auger AP, Forbes-Lorman RM: Epigenetic control of vasopressin expression is maintained by steroid hormones in the adult male rat brain. Proc Natl Acad Sci USA 2011; 108: 4242-4247.
21. Bonsch D, Greifenberg V, Bayerlein K, Biermann T, Reulbach U, Hillemacher T, Kornhuber J, Bleich S: Alpha-synuclein protein levels are increased in alcoholic patients and are linked to craving. Alcohol Clin Exp Res 2005; 29: 763-765.
22. Bleich S, Lenz B, Ziegenbein M, Beutler S, Frieling H, Kornhuber J, Bonsch D: Epigenetic DNA hypermethylation of the HERP gene promoter induces down-regulation of its mRNA expression in patients with alcohol dependence. Alcohol Clin Exp Res 2006; 30: 587-591.
23. Harding AJ, Halliday GM, Ng JL, Harper CG, Kril JJ: Loss of vasopressin-immunoreactive neurons in alcoholics is dose-related and time-dependent. Neuroscience 1996; 72: 699-708.
24. Madeira MD, Sousa N, Lieberman AR, Paula-Barbosa MM: Effects of chronic alcohol consumption and of dehydration on the supraoptic nucleus of adult male and female rats. Neuroscience 1993; 56: 657-672.
25. Paula-Barbosa MM, Silva SM, Andrade JP, Cadete-Leite A, Madeira MD: Nerve growth factor restores mRNA levels and the expression of neuropeptides in the suprachiasmatic nucleus of rats submitted to chronic ethanol treatment and withdrawal. J Neurocytol 2001; 30: 195-207.
26. Silva SM, Paula-Barbosa MM, Madeira MD: Prolonged alcohol intake leads to reversible depression of corticotropin-releasing hormone and vasopressin immunoreactivity and mRNA levels in the parvocellular neurons of the paraventricular nucleus. Brain Res 2002; 954: 82-93.
27. Sousa N, Madeira MD, Ruela C, Paula-Barbosa MM: Structural reorganization in the supraoptic nucleus of withdrawn rats following long-term alcohol consumption. Alcohol Clin Exp Res 1995; 19: 879-885.
28. De Vries GJ, Buijs RM: The origin of the vasopressinergic and oxytocinergic innervation of the rat brain with special reference to the lateral septum. Brain Res 1983; 273: 307-317.
29. De Bold AJ: Atrial natriuretic factor: A hormone produced by the heart. Science 1985; 230: 767-770.
30. Wiedemann K, Jahn H, Kellner M: Effects of natriuretic peptides upon hypothalamo-pituitary-adrenocortical system activity and anxiety behaviour. Exp Clin Endocrinol Diabetes 2000; 108: 5-13.
31. Kellner M, Jahn H, Wiedemann K: Natriuretic peptides and panic disorder: Therapeutic prospects. Expert Rev Neurother 2003; 3: 381-386.
32. Kiefer F, Witt SH, Frank J, Richter A, Treutlein J, Lemenager T, Nothen MM, Cichon S, Batra A, Berner M, Wodarz N, Zimmermann US, Spanagel R, Wiedemann K, Smolka MN, Heinz A, Rietschel M, Mann K: Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate. Pharmacogenomics J 2011; 11: 368-374.
33. Ito S, Ohtsuki S, Katsukura Y, Funaki M, Koitabashi Y, Sugino A, Murata S, Terasaki T: Atrial natriuretic peptide is eliminated from the brain by natriuretic peptide receptor-Cmediated brain-to-blood efflux transport at the blood-brain barrier. J Cereb Blood Flow Metab 2011; 31: 457-466.
34. Davies MN, Volta M, Pidsley R, Lunnon K, Dixit A, Lovestone S, Coarfa C, Harris RA, Milosavljevic A, Troakes C, Al-Sarraj S, Dobson R, Schalkwyk LC, Mill J: Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol 2012; 13:R43.